News

Longaevus Team Participates in ARDD 2024

We're excited to share that the Longaevus team participated in ARDD 2024, a leading global conference on ageing research and drug discovery.

We're excited to share that the Longaevus team participated in ARDD 2024.
Longaevus Co-Authors Pioneering Article on Longevity Clinic Model in «Aging and Disease»

We are pleased to share that Longaevus has co-authored a groundbreaking article on the Longevity Clinic model.

Longaevus Scientific Advisor Alexander Fedintsev Honored with «Rising Star» Award at Longevity Summit Dublin!

We are thrilled to announce that Longaevus Scientific Advisor Alexander Fedintsev has been awarded the prestigious «Rising Star» accolade at the Longevity Summit in Dublin.

Elastin Biosciences Unveils Groundbreaking Preclinical Results in Elastin Preservation and Restoration

Elastin Biosciences, a revolutionary biotechnology spin-off from Longaevus Technologies, has announced sensational preclinical in vivo results.

Elastin Biosciences to Join 2024 BIO International Convention in San Diego

Elastin Biosciences to Join 2024 BIO International Convention in San Diego

Elastin Biosciences, a spin-off from Longaevus Technologies, will participate in the 2024 BIO International Convention in San Diego, June 3-6, 2024.
SeneXell CEO Introduces Fresh Approach to Senescence at The Longevity Biotech Fellowship

Francesca Lugarini, CEO of SeneXell, shared an innovative strategy for tackling cellular senescence at The Longevity Biotech Fellowship

Francesca Lugarini, CEO of SeneXell, shared an innovative strategy for tackling cellular senescence at The Longevity Biotech Fellowship on May 16, 2024.
CEO of Remodel is discussing with Aubrey de Grey new ideas

Discussion to explore innovative strategies to stop advanced glycation end products (AGE) signaling pathways that are involved in the aging process. various organs and systems in Vitalia City.

CEO of Remodel is discussing with Aubrey de Grey new ideas
Elastin Bioscience at the BIO CEO and Investor Conference

The BIO CEO and Investor Conference is an important event for the biotech industry to unite and collectively influence the future investment trajectory of biotech.

Ivan Morgunov, founder of Longaevus Technologies; Sherif Idriss, CEO of Elastin Biosciences (Longaevus’ spin-off) at the BIO CEO & Investor Conference 2024 in New York.
Longaevus is one of the sponsors of Life Extension Conference in Vitalia, Roatan

Longaevus Technologies proudly emerged as one of the sponsors for the VitaDAO Life Extension Conference held in Vitalia City.

Longaevus is one of the sponsors of Life Extension Conference in Vitalia, Roatan
The Longaevus team took part in BIO-Europe

The participation of the Longaevus Technologies team in the 9th annual BIO-Europe event held on November 6-8, 2023 in Munich, Germany.

Ivan Morgunov (founder of Longaevus Technologies), Sherif Idriss (CEO of Elastin Therapeutics (Longaevus’ spin-off)), Francesca Lugarini (CEO of SeneXell Project (Longaevus’ spin-off)) and Alexander Fedintsev (a specialist in extracellular matrix biology and advisor of Longaevus Biotech) at Bio-Europe 2023 in Munich, Germany.
Longaevus Technologies announced the allocation of Elastin Biosciences

Longaevus Technologies is proud to announce the release of Elastin Biosciences, a significant breakthrough in the field of elastin-related health.

Longaevus Technologies is proud to announce the release of Elastin Biosciences, a significant breakthrough in the field of elastin-related health.
Longaevus Technologies has received a grant from HEALS

HEALS has awarded a grant for a project to extend the life of mice and counteract numerous age-related cell changes.

Longaevus Technologies at the Longevity Nation conference

At the Longevity Nation conference, Alexey Moskalev presented the results of a Pilot Mice experiment during the session on “Enhancing Research, Development, and Education for Healthy Longevity.”

Prof. Alexey Moskalev (founder and chief-scientist of Longaevus Technologies), Bar-Ilan University, Israel.
Longaevus founder Alexey Moskalev speak at the ARDD Congress

Alexey Moskalev (Founder of Longaevus) will speak at the ARDD Congress with a report on a combination approach to extending the life of mice.

Alexey Moskalev (founder and chef-scientist of Longaevus Technologies) Copenhagen, Denmark, 2022.
Longaevus Technologies at ARDD 2022

The Longaevus team attended the ARDD Congress in 2022.

Ivan Morgunov (the founder of Longaevus Technologies), Alexey Moskalev (founder and chief scientist of Longaevus Technologies) and Olga Borysova (Longaevus entrepreneur in residence) at ARDD 2022 in Copenhagen, Denmark, 2022.